ResearcherEmory UniversityNo recent work listed
Lauren McLendon Postlewait
Matched on ORCID iD 0000-0003-1038-1743; OpenAlex author ID A5072697082. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: 2 papers
Papers 3
- Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial. Co-author DOI 10.1002/jso.24317↗
- Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Editio… Co-author DOI 10.1245/s10434-016-5093-7↗
- Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TN… Co-author DOI 10.1245/s10434-015-4861-0↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David A. Kooby · 3 shared papers, 2015–2016 · strength 0.14
- Paper Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Pha… DOI 10.1002/jso.24317↗
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Volkan N. Adsay · 3 shared papers, 2015–2016 · strength 0.14
- Paper Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Pha… DOI 10.1002/jso.24317↗
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Juan Manuel Sarmiento · 3 shared papers, 2015–2016 · strength 0.14
- Paper Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Pha… DOI 10.1002/jso.24317↗
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Shishir Kumar Maithel · 3 shared papers, 2015–2016 · strength 0.14
- Paper Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Pha… DOI 10.1002/jso.24317↗
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Bassel F. El‐Rayes · 3 shared papers, 2015–2016 · strength 0.14
- Paper Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Pha… DOI 10.1002/jso.24317↗
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Olca Baştürk · 2 shared papers, 2015–2016 · strength 0.09
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Burcu Saka · 2 shared papers, 2015–2016 · strength 0.09
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Michelle Dian Reid · 2 shared papers, 2015–2016 · strength 0.09
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Pelin Bağcı · 2 shared papers, 2015–2016 · strength 0.09
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Alyssa M. Krasinskas · 2 shared papers, 2015–2016 · strength 0.09
- Paper Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Renderi… DOI 10.1245/s10434-016-5093-7↗
- Paper Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Propos… DOI 10.1245/s10434-015-4861-0↗
- Cecilia Grace Ethun · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.